Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mepolizumab in COPD with Eosinophilic Bronchitis
NCT01463644Phase 3Completed
- Sponsor
- McMaster University
- Start
- Jan 2012
- Primary completion
- Aug 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of mepolizumab in chronic obstructive pulmonary disease (COPD), sponsored by McMaster University. Started Jan 2012; status: completed.
02
Drugs
mepolizumab
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01463644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01463644.